Assessing patent owners’ fightback against hedge fund IPRs
With the PTAB soon to issue institution decisions on the controversial IPR petitions from the Coalition for Affordable Drugs and Ferro Ferrum Capital, patent owners have hit back through sanctions and additional discovery, and a complaint for attempted extortion
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: